Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people’s lives, today announces a new contract with the Institute of Immunology and Genetics (‘IIG’ or the ‘Institute’) a leading molecular genetic laboratory in Kaiserslautern, Germany, equipped with state-of-the-art equipment and comprehensive human genetic and bioinformatic expertise. From analysis […]
Following Getinge’s acquisition of Applikon Biotechnology B.V. in January 2020, all Applikon products will be marketed by Getinge France, Getinge Sweden and Getinge DACH from April 1st, 2021. Applikon Biotechnology B.V. is a world leader in the design and production of bioreactors and associated systems for biopharmaceutical research and production. The company was acquired by Getinge […]
New acquisition will help support single-use technology demand driven by COVID-19 PORT WASHINGTON, N.Y. — Pall Corporation, an operating company within Danaher Corporation’s Life Sciences platform filtration, separation and purification technologies, has finalized a shareholding acquisition of Pall-Austar Lifesciences Limited, a joint venture (JV) established by Pall and Austar. This acquisition will expand manufacturing capacity […]
· Agilent Technologies to manufacture custom microarray based on OBD’s proprietary probe sets for EpiSwitch® Explorer Array Kit · First commercial microarray kit available for high-resolution 3D genome profiling and biomarker discovery · Kit accompanied by EpiSwitch® Data Portal to enable powerful, intuitive analytics of research data and access to 3D genome knowledgebase · Launch of the EpiSwitch® Explorer Array Kit […]
LEHIGH VALLEY, Pa. — New Horizon Biotech Inc. (NHB) has been awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant for $256,000 to conduct research and development (R&D) work on the effectiveness of horizontal, pressurizable single-use fermentors as scalable replacements for vertical, conventional and single-use fermentors in the production of therapeutically-relevant biologics. With a design based on core engineering […]
The Swedish AI software company Qlucore AB (“Qlucore” or “the Company”) – with more than 200 international customers – today announces that it has secured SEK 30 million before transaction costs in a pre-IPO private placement. The raised capital will predominantly be used to accelerate sales activities and expand the technical team prior to an […]
Partnership combines Viroclinics-DDL’s diagnostic and high-throughput sequencing experience with ENPICOM’s expertise in bioinformatics and immunomics ‘s-Hertogenbosch (The Netherlands) – Life Science Newswire – Viroclinics-DDL, a state-of-the-art Contract Research Organization specialized in molecular diagnostic testing and assay development, and ENPICOM, an innovative bioinformatics software engineering company, announced the approval of their joint MIT Zuid subsidy (SME […]
IP Group plc (LSE: IPO) (“IP Group” or “the Group”), the developer of intellectual property-based businesses, notes that portfolio company Oxford Nanopore Technologies Ltd (“Oxford Nanopore”) has today announced that it has informed its shareholders that it has started the process of preparing for a potential Initial Public Offering (“IPO”). Whilst the timing of a potential […]
Oxford Nanopore has announced that Tim Cowper is taking the role of Chief Financial Officer, and Jordan Herman has joined as General Counsel. “We’re delighted to announce that Tim will be taking on the important role of CFO, and to welcome Jordan to the Company after working with him for so long as external counsel,” […]
CAMBRIDGE, UK – EVONETIX LTD (‘Evonetix’), the synthetic biology company developing a desktop platform for scalable, high-fidelity and rapid gene synthesis, today announced the appointment of Michael Daniels, PhD, as Head of Product Management. In this role, Dr Daniels will be focused on the development and introduction of Evonetix’s first product, a DNA desktop writer. He will […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
